Evolus, Inc. (EOLS) financial statements (2021 and earlier)

Company profile

Business Address 520 NEWPORT CENTER DRIVE
NEWPORT BEACH, CA 92660
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments10813093
Cash and cash equivalents10311093
Short-term investments520 
Receivables1011 
Inventory, net of allowances, customer advances and progress billings36 
Inventory36 
Other undisclosed current assets751
Total current assets:12815294
Noncurrent Assets
Operating lease, right-of-use asset34
Property, plant and equipment11 
Intangible assets, net (including goodwill)778177
Goodwill212121
Intangible assets, net (excluding goodwill)556056
Other noncurrent assets020
Total noncurrent assets:818878
TOTAL ASSETS:209240172
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:9145
Accounts payable  2
Accrued liabilities  4
Employee-related liabilities45 
Other undisclosed accounts payable and accrued liabilities59 
Debt741 
Estimated litigation liability63  
Due to related parties19  
Other undisclosed current liabilities149 
Total current liabilities:180245
Noncurrent Liabilities
Long-term debt and lease obligation447717
Long-term debt, excluding current maturities417417
Operating lease, liability34
Liabilities, other than long-term debt20 0
Deferred rent credit  0
Deferred income tax liabilities0 
Estimated litigation liability20  
Other undisclosed noncurrent liabilities385965
Total noncurrent liabilities:10213782
Total liabilities:28216187
Stockholders' equity
Stockholders' equity attributable to parent(73)7984
Common stock000
Additional paid in capital303293207
Accumulated other comprehensive income 0 
Accumulated deficit(376)(213)(123)
Total stockholders' equity:(73)7984
TOTAL LIABILITIES AND EQUITY:209240172

Income statement (P&L) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
Revenues5735 
Cost of revenue(23)(8) 
Cost of goods and services sold(18)(8) 
Gross profit:3327 
Operating expenses(186)(126)(46)
Operating loss:(153)(99)(46)
Nonoperating income (expense)(10)(6)0
Investment income, nonoperating120
Other nonoperating expense(11)(8) 
Interest and debt expense  (1)
Loss from continuing operations before income taxes:(163)(105)(47)
Income tax expense (benefit)(0)15(0)
Net loss available to common stockholders, diluted:(163)(90)(47)

Comprehensive Income ($ in millions)

12/31/2020
12/31/2019
12/31/2018
Net loss:(163)(90)(47)
Comprehensive loss:(163)(90)(47)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(0)0 
Comprehensive loss, net of tax, attributable to parent:(163)(90)(47)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: